202 related articles for article (PubMed ID: 29855279)
1. Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report.
Yang L; Liu L; Han B; Han W; Zhao M
BMC Cancer; 2018 May; 18(1):618. PubMed ID: 29855279
[TBL] [Abstract][Full Text] [Related]
2. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
Guan J; Luo Z; Xiao Z; Xie Y; Lin L
BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
[TBL] [Abstract][Full Text] [Related]
3. Angiosarcoma of the scalp successfully treated with a single therapy of sorafenib.
Ono S; Tanioka M; Fujisawa A; Tanizaki H; Miyachi Y; Matsumura Y
Arch Dermatol; 2012 Jun; 148(6):683-5. PubMed ID: 22710450
[No Abstract] [Full Text] [Related]
4. A case of cutaneous angiosarcoma successfully treated with eribulin.
Iwamoto K; Fujisawa Y; Ishitsuka Y; Maruyama H; Nakamura Y; Okiyama N; Watanabe R; Fujimoto M
Eur J Dermatol; 2018 Jun; 28(3):410-412. PubMed ID: 29619993
[No Abstract] [Full Text] [Related]
5. Angiosarcoma of the scalp treated with OK-432 and rIL-2.
Miura H; Inui S; Sakai H; Hasebe N; Itami S; Yoshikawa K
Int J Dermatol; 2002 May; 41(5):286-8. PubMed ID: 12100706
[No Abstract] [Full Text] [Related]
6. Partial response of angiosarcoma of the scalp to sorafenib: association with decreased expression of vascular endothelial growth factors and their receptors.
Tamiya H; Kamo R; Kumei A; Yanagihara S; Ishii M; Kobayashi H
Clin Exp Dermatol; 2012 Oct; 37(7):749-52. PubMed ID: 22369131
[TBL] [Abstract][Full Text] [Related]
7. Spontaneous regression of chemotherapy-resistant metastases from a scalp angiosarcoma.
Suzuki M; Matsuzuka T; Ikeda M; Nakaegawa Y; Kobayashi T; Kawase T; Kobari T; Murono S
Fukushima J Med Sci; 2017 Aug; 63(2):106-111. PubMed ID: 28680008
[TBL] [Abstract][Full Text] [Related]
8. A case of advanced scalp angiosarcoma successfully treated with combination chemotherapy of adriamycin, cisplatin and ifosfamide.
Kanat O; Ozet A; Ataergin SA; Arpaci F; Ozturk B; Arpaci F; Ozturk M; Komurcu S; Kuzhan O
Clin Oncol (R Coll Radiol); 2006 Jun; 18(5):426-7. PubMed ID: 16817336
[No Abstract] [Full Text] [Related]
9. Angiosarcoma of the scalp responding to nivolumab: a case report.
Hofer S; Zeidler K; Schipf A; Kempf W; Zimmermann D; Aebi S
Br J Dermatol; 2018 Aug; 179(2):530-531. PubMed ID: 29700818
[No Abstract] [Full Text] [Related]
10. Angiosarcoma of the scalp and face: failure of an interferon alpha treatment.
Guillot B; Raison-Peyron N; Acevedo M; Meunier L; Dandurand M; Meynadier J
Eur J Dermatol; 2000 Jun; 10(4):300-2. PubMed ID: 10846259
[TBL] [Abstract][Full Text] [Related]
11. Complete long-term response of angiosarcoma of the scalp with cervical lymph node metastases treated with a combination of weekly and monthly docetaxel.
Nakamura Y; Nakamura Y; Hori E; Furuta J; Kawachi Y; Otsuka F
Br J Dermatol; 2010 Dec; 163(6):1357-8. PubMed ID: 20731655
[No Abstract] [Full Text] [Related]
12. [A case of angiosarcoma of the scalp with severe fluid retention after administering docetaxel].
Namba R; Kanazawa J; Yamamoto Y; Itou S; Nawa T
Gan To Kagaku Ryoho; 2011 May; 38(5):807-10. PubMed ID: 21566442
[TBL] [Abstract][Full Text] [Related]
13. Angiosarcoma of the head and neck. The UCLA experience 1955 through 1990.
Mark RJ; Tran LM; Sercarz J; Fu YS; Calcaterra TC; Juillard GF
Arch Otolaryngol Head Neck Surg; 1993 Sep; 119(9):973-8. PubMed ID: 8357598
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of angiosarcoma of the scalp with apatinib: a case report.
Ji G; Hong L; Yang P
Onco Targets Ther; 2016; 9():4989-92. PubMed ID: 27563253
[TBL] [Abstract][Full Text] [Related]
15. Angiosarcoma of the scalp with complete response to a biweekly gemcitabine and docetaxel (GEMDOC) chemotherapy regimen.
Shkoukani MA; Carron MA; Tulunay O; Kucuk O; Lin HS
Ear Nose Throat J; 2011 Jan; 90(1):E26-9. PubMed ID: 21229496
[TBL] [Abstract][Full Text] [Related]
16. Apatinib: A Review in Advanced Gastric Cancer and Other Advanced Cancers.
Scott LJ
Drugs; 2018 May; 78(7):747-758. PubMed ID: 29663291
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Penel N; Bui BN; Bay JO; Cupissol D; Ray-Coquard I; Piperno-Neumann S; Kerbrat P; Fournier C; Taieb S; Jimenez M; Isambert N; Peyrade F; Chevreau C; Bompas E; Brain EG; Blay JY
J Clin Oncol; 2008 Nov; 26(32):5269-74. PubMed ID: 18809609
[TBL] [Abstract][Full Text] [Related]
18. Combined nab-paclitaxel and irradiation for large cutaneous angiosarcoma of the face and scalp with pulmonary metastases.
André F; Frischhut N; Walder A; Skvortsov S; Schmuth M; Nguyen VA
J Dtsch Dermatol Ges; 2020 Jul; 18(7):754-757. PubMed ID: 32469459
[No Abstract] [Full Text] [Related]
19. Liposomal doxorubicin in the treatment of metastasized angiosarcoma.
Waldmann V
Br J Dermatol; 2003 Mar; 148(3):606. PubMed ID: 12653770
[No Abstract] [Full Text] [Related]
20. Complete remission of treatment-refractory advanced angiosarcoma of the scalp by protracted intralesional interleukin-2 therapy.
Gebhardt C; Ziegler B; Stadler S; Goerdt S; Utikal J
Br J Dermatol; 2015 Apr; 172(4):1156-8. PubMed ID: 25204400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
